Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate whether treatment with (SEROQUEL SR)
quetiapine fumarate sustained release (SR) for 9 weeks compared to placebo will improve
elderly patients with generalised anxiety disorder.
PLEASE NOTE: Seroquel SR and Seroquel extended release(XR) refer to the same formulation. The
SR designation was changed to XR after consultation with FDA.